AdvisorShares Psychedelics ETF PSIL
20.07 USD +0.09 (+0.45%)
At closeNov 11, 2026, 4:00 PM EST
20.07 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
19.89 Day range 20.21
15.64 52-week range 27.02
- YTD
- +16.89%
- 1 year
- +7.61%
News
benzinga.com NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
benzinga.com COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy Compass Pathways' stock surges after late-stage depression trial success.
benzinga.com Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compound, Lucid-MS, in a Phase 1 trial.
benzinga.com 'Texas Governor Signs Bill To Create Ibogaine Research Consortium, Aiming To Develop FDA-Approved Psychedelic Drug' - Marijuana Moment https://www.marijuanamoment.net/texas-governor-signs-bill-to-create-ibogaine-research-consortium-aiming-to-develop-fda-approved-psychedelic-drug/
benzinga.com "Colorado Governor Says Bill He Signed Allowing Psychedelic Convictions To Be Pardoned Marks A Step 'Towards A Fairer Future'" - Marijuana Moment https://www.marijuanamoment.net/colorado-governor-says-bill-he-signed-allowing-psychedelic-convictions-to-be-pardoned-marks-a-step-towards-a-fairer-future/
benzinga.com 'Doctor Seeking To Reschedule Psilocybin To Treat Dying Patients Demands DEA Update After Agency Agreed To Initiate Federal Review' - Marijuana Moment https://www.marijuanamoment.net/doctor-seeking-to-res
benzinga.com 5 ETFs That Beat Market Turmoil With Gains Last Week Last week had Wall Street facing volatility, tech earnings disappointments, mixed labor data, and rising inflation fears. Gold hit record highs.
benzinga.com Why Is Penny Stock Clearmind Gaining Today? Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcohol use disorder.